Coagulation Curve Differentiation for Faster Delay Cause Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional blood coagulation tests face challenges in accurately distinguishing between coagulation factor inhibitors and lupus anticoagulants due to qualitative graph patterns and require lengthy heating and measurement times, making it difficult to determine the cause of coagulation delays.

Innovation Solution

A method involving the analysis of coagulation reaction curves through differentiation to calculate center-of-gravity points and utilize parameters such as vT, vH, pT, pH, and mT to quantify coagulation factors and identify the cause of coagulation time prolongation, using mixed plasma with and without heating treatments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional cross-mixing test with heating treatment is performed to distinguish between coagulation factor inhibitors and lupus anticoagulants, then diagnostic accuracy is improved, but test time is significantly increased

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidtest time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary classification of coagulation abnormalities using waveform parameters (maximum coagulation rate, maximum coagulation acceleration, maximum coagulation deceleration) before conducting the cross-mixing test. This preliminary action identifies likely candidates (inhibitors vs. other causes) so that heating treatment is only applied when necessary, significantly reducing overall test time while maintaining diagnostic accuracy for inhibitor detection

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the parameter being measured from traditional APTT time alone to multiple waveform parameters (coagulation rate, acceleration, deceleration) that provide richer information about the coagulation process. This allows for more accurate classification and reduces reliance on lengthy heating procedures, as the waveform characteristics themselves provide diagnostic clues

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If qualitative graph patterns are used to determine coagulation delay causes, then test complexity is reduced, but measurement precision deteriorates

Engineering Contradiction:
Improvetest complexityVSAvoiddiagnostic precision
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent transforms the qualitative graph pattern analysis into quantitative measurements by extracting specific waveform parameters (maximum coagulation rate, maximum coagulation acceleration, maximum coagulation deceleration and their corresponding times). These numerical parameters provide objective, precise data for classification while maintaining relatively simple test procedures

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the subjective visual interpretation of graph patterns with automated computational analysis of waveform parameters. The analysis apparatus automatically calculates and compares numerical values against reference ranges, eliminating human subjectivity and improving diagnostic precision without significantly increasing operational complexity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If multiple coagulation parameters are measured and analyzed, then diagnostic accuracy is improved, but analysis complexity increases

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidanalysis complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the coagulation analysis into distinct phases: initial waveform parameter extraction (maximum rate, acceleration, deceleration), preliminary classification based on these parameters, and then selective cross-mixing test only for inhibitor suspects. This segmentation breaks down the complex analysis into manageable steps, improving diagnostic accuracy while controlling analysis complexity through structured progression

Inventive Principle:
Principle #1Segmentation

Data Source

PatentEP3882628B1Analysis method for analyzing a coagulation characteristics of a blood specimen
Publication Date: 2025.12.24 SEKISUI MEDICAL CO LTD
  • EP3882628B1 patent drawingFigure 1~2
  • EP3882628B1 patent drawingFigure 3~4
  • EP3882628B1 patent drawingFigure 5A~5B

AI summary

Excellent analysis of a coagulation characteristic of a blood sample is implemented. A method for analyzing a coagulation characteristic of a blood specimen according to the present invention includes: acquiring data for a coagulation reaction curve indicating a coagulation reaction amount of a mixed solution containing a blood sample and a reagent with respect to reaction time; calculating data for a differential curve obtained by differentiating the coagulation reaction curve; calculating information related to a center-of-gravity point of the differential curve; and evaluating the coagulation characteristic of the blood sample using the information related to the center-of-gravity point.